General MedicationsVAGINALStandard
TERCONAZOLE
TERCONAZOLE
Standard Dose
80MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview TERCONAZOLE is listed in Drugs@FDA under application 077553 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient TERCONAZOLE Form and strength SUPPOSITORY;VAGINAL - 80MG Sponsor SUN PHARMA CANADA Submission history Latest submission status date: 2016-02-23 00:00:00.
Structured Monograph
Clinical summary
Approval overview TERCONAZOLE is listed in Drugs@FDA under application 077553 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TERCONAZOLE Form and strength SUPPOSITORY;VAGINAL - 80MG Sponsor SUN PHARMA CANADA Submission history Latest submission status date: 2016-02-23 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.